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Abstract: Reactive oxygen intermediates (ROI)
play an important role in cell signaling in addition
to their role in microbial killing. We have shown
previously that exogenous ROI regulate activity of
the enzyme 5-lipoxygenase (5-LO) in alveolar mac-
rophages (AM). Here, we examined the role of
endogenous ROI, specifically generated by NADPH
oxidase, in the regulation of leukotriene (LT) syn-
thetic capacity in AM, which from NADPH oxidase
knockout (KO) mice, was significantly less than
that from wild-type (WT) AM. The decrease in LT
synthesis could not be explained by reduced re-
lease of the substrate for 5-LO, arachidonic acid.
However, the expression of 5-LO was reduced
50% in AM from NADPH oxidase KO mice com-
pared with WT mice. Reduced 5-LO expression
could be reproduced by treating WT AM with ROI
scavengers and with selective pharmacologic inhib-
itors of NADPH oxidase. Furthermore, condi-
tioned media from WT AM augmented 5-LO me-
tabolism in AM from NADPH oxidase KO mice.
This decrease in 5-LO expression in NADPH oxi-
dase KO cells was associated with decreased ex-
pression of the transcription factors, specificity
protein-1 and early growth response-1, both of
which are known to regulate 5-LO mRNA expres-
sion. These data reveal a previously unrecognized
influence of endogenous ROI generated by
NADPH oxidase on expression of the key LT bio-
synthetic protein, 5-LO. In view of the antimicro-
bial actions of LT, a reduction in LT synthetic
capacity by AM from NADPH oxidase KO mice
may contribute to the susceptibility of these ani-
mals to infection. J. Leukoc. Biol. 82: 1585–1591;
2007.
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INTRODUCTION
Leukotriene (LT) synthesis from arachidonic acid (AA) is ini-
tiated by the Ca2-dependent activation of 5-lipoxygenase
(5-LO) to form LTA4, which is the precursor for formation of the
two major groups of LT: LTB4 and the cysteinyl LT (cysLT),
LTC4, D4, and E4 [1]. LT are proinflammatory mediators, which
play an important role in disease states such as asthma [2–4]
and lung injury [5]. They are also produced in high levels in
pneumonia [6], and recently, LT have been implicated as
having a role in host defense against microbial infection
[7–10]. Specifically, LT boost phagocytosis and killing of mi-
croorganisms in a number of phagocytic cell types including
alveolar macrophages (AM) [9], blood neutrophils (PMN) [11],
and peripheral blood monocytes [12]. Synthesis of LT following
cell activation or phagocytosis of microorganisms is accompa-
nied by the production of other mediators including reactive
oxygen intermediates (ROI) [13].
ROI, such as superoxide, are formed in macrophages con-
stitutively and especially following phagocytosis or stimulation
by various biologically active substances including PMA, LPS,
TNF-, and IL-1. ROI may be generated from a variety of
sources including activation of mitochondrial enzymes [14],
endoplasmic reticulum enzymes [15], and peroxisomes en-
zymes [16]. The enzyme NADPH oxidase is an important
source of ROI with a key role in antimicrobial killing [17] and
cell signaling. In addition, activation of oxygenase enzymes,
e.g., 5-LO and cyclooxygenase, may result in ROI formation
[13, 18].
ROI in turn are also known to regulate LT in several ways.
First, ROI have a biphasic concentration-dependent effect on
5-LO activity, with low doses necessary for enzyme activity but
higher doses causing inactivation [19–21]. It is thought that
these effects reflect alterations in redox tone, which influence
the nonheme iron in the catalytic site of 5-LO. Second, ROI
have also been shown to degrade LT in PMN [22]. This may
account for reports that PMN from subjects with chronic gran-
ulomatous disease displayed greater levels of LTB4 and LTC4
[23]. Despite the enormous impact of respiratory infections on
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morbidity and mortality and the fact that NADPH oxidase and
LT participate in antimicrobial defense, little is known about
the influence of NADPH oxidase on LT biosynthesis.
In this study, we examined the role of NADPH oxidase in the
regulation of 5-LO metabolism in AM, the resident defender of
the pulmonary alveolus. We demonstrate for the first time that
genetic and pharmacologic disruption of NADPH oxidase re-
sults in impaired LT biosynthesis and define relevant mecha-
nisms for this interaction.
MATERIALS AND METHODS
Cell isolation and culture of rat and murine AM
Mice
AM were isolated from C57BL/6 NADPH oxidase wild-type (WT) and knock-
out (KO; gp91phox /) mice (Jackson Laboratory, Bar Harbor, ME, USA) [24,
25]. After anesthesia with ketamine (80–120 mg/kg) and xylazine (5–10
mg/kg) by i.p. injection, mice were killed by exsanguination. Following expo-
sure of the tracheobronchial tree, harvesting of AM was performed by bron-
choalveolar lavage (BAL) using 1 ml aliquots of EDTA-containing phosphate
buffer to a total of 5 ml. AM (0.5–1.0106) were obtained per mouse. As
assessed by Diff-Quik staining, AM purity of cell monolayers was 98%
following a 1-h adherence step. Viability was 95%, as assessed by trypan
blue exclusion. Isolated AM were resuspended in LPS-free DMEM (Life
Technologies, Grand Island, NY, USA) at 0.5  106/ml and plated as follows:
0.2 ml/well in 96-well plates for enzyme immunoassay (EIA) and 5 ml/50 mm
culture plate for immunoblot analysis.
Rats
AM were also obtained from 150 g-specific, pathogen-free, female Wistar rats,
as described previously [26]. AM (8–10106) were obtained per rat. BAL cells
were pelleted by centrifugation at 500 g and were 90% AM when adhered,
as determined by Diff-Quik staining.
Coincubation of AM from NADPH oxidase WT
and KO mice
AM were harvested from NADPH oxidase WT and KO animals. Using Costar
Transwell inserts (Cole-Palmer, Vernon Hills, IL, USA), AM from the WT and
KO animals were plated in wells or inserts separately, and then, inserts were
placed in wells for overnight incubation. Specifically, AM from KO animals
were plated in wells with or without inserts containing AM from WT animals.
After the inserts were removed, cells in the wells were subsequently washed
and stimulated with or without A23187 or harvested for Western blot analysis.
Quantitation of 5-LO metabolism in intact cells
Following adherence and subsequent incubation for 16 h in DMEM containing
10% FCS (HyClone, Logan UT, USA), the cells were washed three times in
media and subsequently incubated with or without Ca2 ionophore A23187 (1
M, Calbiochem, La Jolla, CA, USA) to stimulate maximal release and
metabolism of endogenous AA. Capacity for 5-LO metabolism in intact cells
was measured by EIA (Cayman Chemicals, Ann Arbor, MI, USA) determina-
tion in cell-free supernatants of the predominant 5-LO products cysLT in
murine cells and LTB4 in rat cells. HPLC analysis was used to quantify
A23187-stimulated AA release, following overnight prelabeling of cells with
[3H]AA (Du Pont-New England Nuclear, Boston, MA, USA) [27]. Cells were
stimulated in the presence of 0.1% BSA (Sigma Chemical Co., St. Louis, MO,
USA), which binds AA and prevents its metabolism and reacylation into
membrane lipids. HPLC analysis of radiolabeled cell products was performed
on supernatants of cells activated with A23187 in the absence of albumin to
permit metabolism and thereby confirms the EIA results about LT synthesis
and determines effects on other pathways such as cyclooxygenase.
5-LO cell-free activity assay
Freshly isolated rat AM (25106 cells) were suspended immediately in cold
homogenization buffer (50 mM Tris, pH 7.8, NaCl 150 nM) containing anti-
proteases (Roche Complete protease inhibitor cocktail tablet) and disrupted
using a Branson sonifier (100% duty cycle, 315 s). The resulting homoge-
nates (250 l per experimental condition) were kept at 4°C, incubated with 10
M diphenylene iodonium (DPI; or vehicle) for 30 min, and then activated with
1 mM CaCl2, 25 M ATP, and 50 M AA for 5 min at 37°C. Incubations were
stopped by the addition of 0.5 ml cold (4°C) stop solution (MeOH/MeCN,
50/50, v/v) containing 12.5 ng 19-OH-PGB2 and PGB2 as internal standards.
The denatured samples were spun to remove the precipitated material, and the
supernatants were harvested for the analysis of 5-hydroxy-eicoasatetraenate
biosynthesis by HPLC. Briefly, the samples were diluted with acidified water
(0.01% acetic acid) to a final volume of 5 ml and then loaded on a C18 Sep-Pak
cartridge (60 mg, Waters Corp., Milford, MA, USA), which had been precon-
ditioned with 2 ml 63/32/5 (MeOH/MeCN/H2O; 0.01% acetic acid) and 2 ml
acidified water. The C18 cartridges were then washed with 2 ml acidified water,
and the eicosanoids were eluted with 1 ml 63/32/5. The resulting eluates were
then analyzed by HPLC [27].
Immunoblot analysis of cytosolic phospholipase
A2 (cPLA2), 5-LO, specificity protein-1 (Sp-1),
and early growth response-1 (Egr-1)
The relative cellular expression of two key proteins involved in LT biosynthe-
sis, cPLA2 and 5-LO, was determined by Western blot analysis. Crude lysates
were prepared as described [27] and subjected to SDS-PAGE by the method of
Laemmli on 10% acrylamide gels. Proteins were transferred overnight to
nitrocellulose membranes and probed with rabbit polyclonal antibodies against
human leukocyte 5-LO (1:3000 dilution, provided by Dr. Jilly Evans, Merck
Frosst, Quebec, Canada [28]); human cPLA2 (1:1000 dilution, provided by Dr.
James Clark, Wyeth Research, Cambridge, MA, USA) [8]; Sp-1 (1:500 dilu-
tion, eBioscience, San Diego, CA, USA); and Egr-1 (1:500 dilution, R&D
Systems, Minneapolis, MN, USA). After washing, blots were incubated for 1 h
with HRP-conjugated anti-rabbit IgG (Amersham, Arlington Heights, IL, USA)
at a dilution of 1:5000. Membranes were then washed and incubated for 1 min
with ECL detection reagents (Amersham) and exposed to film for varying time
periods to ensure that densitometric quantitation was performed under condi-
tions in which band density and exposure time were linearly related. Video
densitometry was performed using Image [National Institutes of Health (NIH)]
software (Scion Corp. Frederick, MD, USA).
Modulation of ROI
Scavenging of ROI was performed by adding tetrakis(4-benzoic acid)porphyrin
(TBAP; Calbiochem-Novabiochem, La Jolla, CA, USA), a stable, cell-perme-
able metalloporphyrin, which catalyzes the dismutation of superoxide and
hydrogen peroxide [29]. Relatively selective pharmacologic inhibition of
NADPH oxidase was performed by using a 10-M concentration of the
flavoprotein inhibitor DPI overnight [30] (Sigma Chemical Co.).
Data analysis
Where indicated, data were expressed as mean 	 SEM. Intergroup differences
were analyzed by ANOVA, and statistical significance was assessed by the
Scheffe test; P 
 0.05 was considered significant.
RESULTS
ROI regulate LT synthesis in murine AM
We have shown previously that low concentrations of exoge-
nous ROI stimulate LT synthesis in rat AM [21]. We now
wished to assess the role endogenous ROI played in regulation
of LT synthesis in AM using a combination of pharmacological
and genetic approaches. The ROI scavenger TBAP suppressed
cellular 5-LO metabolism (Fig. 1A), indicating that endoge-
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nous ROI play a role in up-regulating LT synthesis in murine
AM, as they do in rat AM.
Reduced LT synthesis in AM from NADPH
oxidase KO mice
We next used a genetic approach to determine specifically the
role of ROI derived from NADPH oxidase in regulating AM LT
synthesis. In response to the potent stimulus A23187, synthe-
sis of CysLT, the major 5-LO product of murine AM, was
decreased in cells from NADPH oxidase KO mice compared
with AM obtained from WT mice of the same background strain
(Fig. 1B). Treatment with a relatively selective NADPH oxi-
dase inhibitor, DPI, also reduced the maximum A23187-stim-
ulated LTB4 synthesis in rat AM (Fig. 1C). However, when we
examined the direct effect of DPI on 5-LO cell-free activity in
rat AM whole cell homogenates, we demonstrated no effect
(mean 88.2%; n2) compared with control.
Effect of NADPH oxidase on macrophage
AA release
Any change in cellular 5-LO metabolism can be dictated by
upstream availability of substrate for the enzyme 5-LO. There-
fore, we examined the release of AA, the substrate for the 5-LO
enzyme. As shown in Figure 2A, there was no change in
stimulated AA release from [3H]AA-prelabeled cells obtained
from NADPH oxidase KO mice compared with AM from WT
mice. The mean and SEM for AA release by AM from NADPH
oxidase KO mice were 99.0 	 5.8% (n3; Pns) of that
determined for cells from WT mice. The mean release of
[3H]AA was 0.81 	 0.52% of incorporated radioactivity in AM
from NADPH oxidase WT mice. In keeping with the unaltered
release of AA in AM from NADPH oxidase KO mice, there was
also no difference in cPLA2 expression (Fig. 2B). Levels of
cyclooxygenase metabolites determined by HPLC analysis
were unchanged as expected in NADPH oxidase KO mice
compared with WT mice (data not shown), as there was no
increase in AA release.
Reduced 5-LO expression in AM from NADPH
oxidase KO mice
As shown in Figure 3A, the expression of 5-LO, as determined
by Western blot analysis, was decreased significantly (by
50%) in AM from NADPH oxidase KO mice compared with
WT controls. Mean densitometry of Western blots from six
independent experiments demonstrated 5-LO expression in KO
at 51.3 	 12.5% of the WT level (P
0.05; Fig. 3A).
Scavenging ROI reduces 5-LO expression and
activity in AM
Having shown reduced 5-LO expression in AM from NADPH
oxidase KO mice compared with WT mice, we next sought to
determine if this finding could be reproduced pharmacologi-
cally in vitro. We therefore examined the effect of treating
macrophages with the relatively selective NADPH oxidase
inhibitor DPI. Treatment of rat AM with DPI (10 M) for 16 h
led to decreased expression of 5-LO (Fig. 3B), consistent with
an effect of NADPH oxidase on 5-LO expression (31.5	2.5%
of control levels; P
0.05; n3). In addition, rat AM, incu-
bated with and without the ROI scavenger TBAP (50 M) for
16 h, demonstrated reduced expression of 5-LO in parallel with
the decrease in LT synthetic capacity when compared with
control cells (Fig. 3C).
Reconstitution of AM LT synthesis from NADPH
oxidase KO mice
As the experiments described above indicated that reduced
ROI generation was associated with a reduction in cellular
Fig. 1. Endogenous ROI regulates LT synthesis in murine AM. (A) Murine AM were incubated for
16 h with or without the ROI scavenger TBAP (50 M) in LPS-free DMEM containing 10% FCS. The
cells were washed and then stimulated with A23817 (1 M) for 30 min at 37°C, and the medium was
analyzed for cysLT by EIA. The absolute quantity of cysLT synthesized in response to A23187 under
control conditions was 4347 	 1224 pg/ml. Mean data from three experiments are shown; *, P 
0.05. (B) Murine AM from NADPH oxidase WT and KO mice were adhered in LPS-free DMEM for 1 h, washed, and incubated with LPS-free DMEM
containing 10% FCS. Following washing, the cells were stimulated with A23817 (1 M) for 30 min at 37°C. The medium was then analyzed for cysLT
by EIA. Mean data from three experiments are shown. The absolute level of cysLT produced by AM from NADPH oxidase WT mice was 3572 	 493.4
pg/ml; †, P 
 .001; n  3. (C) AM from rats were incubated with and without the NADPH oxidase inhibitor DPI (10 M) for 16 h in LPS-free DMEM
containing 10% FCS. The cells were subsequently washed, plated with fresh DMEM, and stimulated with or without A23187 (1 M) for 30 min. LTB4
was quantitated in medium by EIA, and data are expressed as percent of control. The absolute level of LTB4 produced by rat AM was 3675 	 562.6 pg/ml.
Mean data from four experiments are shown; *, P 
 0.001; n  4.
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ability to synthesize LT, we wished to determine if adding back
conditioned media from AM from NADPH oxidase KO cells
restored 5-LO metabolic capacity. AM from NADPH oxidase
WT and KO mice were incubated separately and together in a
dual chamber culture plate overnight, allowing the conditioned
media from each cell type to bathe the other. The cells incu-
bated alone and in combination were then separated and
stimulated with A23187 for 30 min. LT generation was in-
creased in the AM from the NADPH oxidase KO mice, which
had been exposed to conditioned media from cells from
NADPH oxidase WT mice (Fig. 4A). Furthermore, condi-
tioned media from AM from NADPH oxidase WT mice also
partially restored 5-LO expression in AM from KO mice (Fig.
4B). These observations suggest that mediators elaborated by
AM from NADPH WT animals can partially reconstitute LT
synthesis in cells from NADPH oxidase null animals.
Reduced expression of Sp-1 and Egr-1 in
DPI-treated AM and in AM from NADPH oxidase
KO mice
Sp-1 and Egr-1 are zinc finger transcription factors, which
regulate transcription of many inflammatory genes, including
5-LO, by binding to the G  C-rich promoter sequence. Sp-1
may activate the murine 5-LO promoter by interacting directly
with the basal transcription apparatus or by recruitment of a
coactivator [31]. Likewise, Egr-1 is known to activate the
human 5-LO promoter [32]. The cysteine residues on zinc
finger transcription factors are sensitive to the redox state of the
cell [33], and increased expression and activation of Sp-1 and
Egr-1 occur following treatment of cells with H2O2 [34, 35].
Therefore, we examined the expression of Sp-1 and Egr-1 in
AM treated with DPI for 16 h. Sp-1 and Egr-1 expression was
decreased markedly in AM from DPI versus untreated AM
(Fig. 5A). Likewise, expression of Sp-1 and Egr-1 was de-
creased in AM from NADPH oxidase KO mice compared with
WT mice (Fig. 5B).
DISCUSSION
Chronic granulomatous disease encompasses a heterogeneous
group of disorders characterized by genetic defects in the
ability of phagocytes to generate ROI from molecular oxygen
[36, 37]. Specifically, these involve mutations, which result in
the loss or functional inactivation of one of the components of
the multicomponent NADPH oxidase complex. The most com-
mon form of chronic granulomatous disease (accounting for
70% of cases) arises from mutations in the gene encoding
gp91phox [17]. Patients with chronic granulomatous disease
typically experience recurrent infections caused by bacterial
and fungal pathogens. In descending order of frequency, these
infections include pneumonia, suppurative adenitis, osteomy-
elitis, bacteremia/fungemia, and superficial skin infections.
The recent recognition that endogenous LT are also necessary
for optimal innate immunity in vivo and phagocytosis and
killing in vitro highlights the potential significance of the
interactions between ROI and enhanced LT synthesis.
Our study used genetic and pharmacologic approaches to
demonstrate for the first time that NADPH oxidase up-regu-
lates LT synthesis in AM. This represents a selective up-
regulation of 5-LO metabolism mediated via augmented ex-
pression of 5-LO expression but not of cPLA2 with increased
AA release. Conditioned media of AM from WT NADPH
oxidase mice partially restored LT synthesis and 5-LO expres-
sion in cells from NADPH oxidase KO animals. It is likely that
other mediators and cytokines including IFN-, apart from
ROI in the conditioned media, resulted in this increase in LT
synthesis and 5-LO expression. The transcription factors Sp-1
Fig. 2. No change in stimulated AA release from [3H]AA-prelabeled cells
obtained from NADPH oxidase KO mice compared with AM from WT mice.
(A) Murine AM from NADPH oxidase WT and KO mice were prelabeled with
[3H]AA overnight, washed, and stimulated with A23187 (1 M) for 30 min in
the presence of 0.1% BSA. Free [3H]AA in cellular supernatants were sepa-
rated by HPLC. The peak was identified by coelution with an authentic AA
standard and released fatty acids expressed as a percentage of incorporated
radioactivity. A representative profile of three separate experiments is shown.
(B) A representative Western blot from n  3 total experiments demonstrates
the expression of cPLA2 in AM from NADPH oxidase WT and KO mice.
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and Egr-1 appear to play an important role in the up-regulation
of 5-LO expression by NADPH oxidase-generated ROI. Over-
all, the main observations of this manuscript suggest that the
5-LO metabolism in AM is dependent on ROI synthesis by
NADPH oxidase.
Generation of low concentrations of ROI has been shown to
up-regulate LT biosynthesis [21]. Our first step was to demon-
strate that ROI are important in the regulation of LT synthesis
in murine macrophages, similar to their role in rat AM. Scav-
enging cellular ROI with TBAP resulted in a consistent reduc-
tion of LT synthesis in murine AM. These experiments also
further emphasized the importance of endogenous ROI gener-
ation in cellular 5-LO metabolism. Given the recognition that
redox tone influences 5-LO activity, the finding was not sur-
prising. However, the finding that TBAP treatment also re-
duced 5-LO expression in murine and rat AM was unexpected.
Next, we sought to confirm this finding using a genetic model
of impaired ROI generation. We used the NADPH oxidase KO
model because of the known reduced capacity of cells from
these animals to elaborate ROI [13, 24]. Maximal LT synthetic
capacity of AM from NADPH oxidase KO mice was reduced
compared with WT mice. This reduced capacity was not ex-
plained by a difference in AA release, the substrate for the
5-LO enzyme. However, the reduction in LT synthesis was
associated with a reduction in 5-LO expression, in parallel with
the effects observed for treatment of WT cells with TBAP and
DPI. This observation of reduced LT synthesis in AM from
NADPH oxidase KO mice contrasts with that reported for PMN
from patients with chronic granulomatous disease [22]. This
difference may be explained by the lesser capacity of AM than
PMN to generate ROI.
The human [38] and murine [31] 5-LO promoter sites have
been cloned and characterized in a number of cell types. A
number of transcription factors have been shown to interact
with the 5-LO promoter, including zinc finger transcriptional
proteins such as Sp-1 and Egr-1 [31, 39–41]. ROI are known
to regulate these zinc finger sites on the transcription factors
[33, 35]. Increased expression and activation of Egr-1 occur
following treatment of cells with hydrogen peroxide [34]. Sp-1
is also regulated by redox-related mechanisms [42]. Transfec-
tion of macrophages with these transcription factors and/or
using Sp-1 and Egr-1 WT and KO mice may help characterize
the role of these factors in the regulation of 5-LO expression in
future studies.
Little is known about the effect of ROI on the expression of
5-LO. Other investigators examined the effect of hyperoxia on
5-LO expression in the lungs of newborn rat lung tissue [43].
LT synthesis and total lung expression of 5-LO were increased
in animals treated with hyperoxia. However, it was unclear if
this effect was because of an increased inflammatory response
Fig. 3. Reduced 5-LO expression in AM from NADPH oxidase KO mice. (A) AM were harvested from NADPH oxidase WT and KO mice. Equal amounts (20
g protein) of crude AM lysate from mice from both genotypes were subjected to immunoblot analysis for 5-LO. To confirm equal loading of protein, the blots were
also probed for -tubulin. (Upper panel) A representative autoradiograph of an experiment from a total of six independent experiments. (Lower panel) Relative
expression of 5-LO in AM from NADPH oxidase KO mice, as assessed by densitometry and expressed as a percent of values derived from control AM; n  6;
*, P 
 0.05. (B) Rat AM were incubated with or without the selective NADPH oxidase inhibitor DPI at a concentration of 10 M for 16 h. Equal amounts (20
g protein) of crude cellular lysate from DPI-treated and control cells were subjected to immunoblot analysis for 5-LO and -tubulin. (Upper panel) Representative
autoradiograph of a Western blot from one of three independent experiments. (Lower panel) Relative expression of 5-LO from DPI-treated AM expressed as a
percent of values derived from control AM; n  3; *, P 
 0.05. (C) AM from rats and mice were incubated with and without the ROI scavenger TBAP (50 M)
for 16 h in LPS-free DMEM containing 10% FCS. Equal amounts (20 g protein) of crude AM lysate were subjected to immunoblot analysis for 5-LO and -tubulin.
(Upper panel) A representative autoradiograph of a Western blot from one of three independent experiments. (Lower panel) Relative expression of 5-LO from
TBAP-treated AM expressed as a percent of values derived from control AM; n  3, *, P 
 0.05.
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with greater leukocyte numbers or if there was increased
expression of these key proteins per cell. Selenium deficiency
is also associated with altered 5-LO metabolism. In animal
models of selenium deficiency and cells incubated under se-
lenium-deficient conditions, increased LT synthesis has been
observed [44]. This phenomenon may be explained by an
increase in the endogenous hydroperoxide tone caused by a
decrease in glutathione (GSH) peroxidase activity and hy-
droperoxide-GSH peroxidase activity. Indeed, leukocytes from
selenium-deficient rats demonstrated a sevenfold increase in
LT synthesis. Taken together, these data support our findings
that ROI regulate LT biosythesis positively.
In summary, ROI play a significant role in up-regulating
5-LO metabolism in AM. A reduced capacity to generate ROI
in NADPH oxidase KO mice is associated with a reduced AM
LT synthetic capacity and a decrease in 5-LO expression. In
view of the role of LT in host defense, this reduction in AM
5-LO metabolic capacity in NADPH oxidase KO mice may
contribute further to the susceptibility of these animals to
infection. Thus, this study provides important new insights into
the link between LT and ROI—two key components in pulmo-
nary host defense. It remains to be determined whether LT
deficiency contributes to the clinical expression of increased
infections in patients with chronic granulomatous disease.
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Fig. 4 . Conditioned media (CM) of AM from NADPH WT mice augments
cellular LT synthesis in AM from KO animals. (A) Using Costar Transwell
inserts, AM from NADPH oxidase KO animals were plated in wells with or
without inserts containing AM from WT animals. After 16 h of culture, the
inserts were removed, and cells in the wells were subsequently washed and
stimulated with A23187 (1 M) for 30 min. A representative experiment of
three performed is shown. (B) Crude lysates were obtained from AM from
NADPH oxidase WT and KO mice incubated alone or following coculture and
subjected to immunoblot analysis for 5-LO. Shown is a representative autoradio-
graph of a Western blot from three independent experiments. n  3; *P 
 0.05.
Fig. 5. Reduced expression of Sp-1 and Egr-1
in DPI-treated AM and in NADPH oxidase KO
mice. (A) Rat AM were incubated with or with-
out the NADPH oxidase inhibitor DPI at a con-
centration of 10 M for 16 h. Crude lysates were
obtained for Western blot analysis. Similarly,
crude lysates were obtained from AM from
NADPH oxidase WT and KO mice. Equal
amounts (20 g protein) of crude cellular lysate
from DPI-treated and control cells were sub-
jected to immunoblot analysis for Egr-1, Sp-1,
and -tubulin. (Upper panel) Representative au-
toradiograph of a Western blot from one (Sp-1) of
three independent experiments and one (Egr-1)
of six independent experiments. (Lower panel)
relative expression of Sp-1 and Egr-1 from DPI-
treated AM, as assessed by densitometry and
expressed as a percent of values derived from
control AM; n  3; *, P 
 .05. (B) AM from
NADPH oxidase WT and KO mice were sub-
jected to immunoblot analysis for Sp-1 and
Egr-1. (Upper panel) Representative autoradio-
graph of a Western blot from three independent
experiments. (Lower panel) Relative expression
of Egr-1 in AM from KO animals compared with
WT animals expressed as a percent of values
derived from WT AM; n  3; *, P 
 0.05.
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